0:00:00.843,0:00:02.888
I'd like to show you a video of some of the models

0:00:02.888,0:00:04.477
I work with.

0:00:04.477,0:00:08.015
They're all the perfect size, and they don't have an ounce of fat.

0:00:08.015,0:00:10.553
Did I mention they're gorgeous?

0:00:10.553,0:00:13.683
And they're scientific models? (Laughs)

0:00:13.683,0:00:16.026
As you might have guessed, I'm a tissue engineer,

0:00:16.026,0:00:18.475
and this is a video of some of the beating heart

0:00:18.475,0:00:20.691
that I've engineered in the lab.

0:00:20.691,0:00:22.573
And one day we hope that these tissues

0:00:22.573,0:00:25.517
can serve as replacement parts for the human body.

0:00:25.517,0:00:27.797
But what I'm going to tell you about today

0:00:27.797,0:00:32.244
is how these tissues make awesome models.

0:00:32.244,0:00:34.971
Well, let's think about the drug screening process for a moment.

0:00:34.971,0:00:37.949
You go from drug formulation, lab testing, animal testing,

0:00:37.949,0:00:40.452
and then clinical trials, which you might call human testing,

0:00:40.452,0:00:42.717
before the drugs get to market.

0:00:42.717,0:00:45.860
It costs a lot of money, a lot of time,

0:00:45.860,0:00:48.670
and sometimes, even when a drug hits the market,

0:00:48.670,0:00:52.605
it acts in an unpredictable way and actually hurts people.

0:00:52.605,0:00:56.692
And the later it fails, the worse the consequences.

0:00:56.692,0:01:00.876
It all boils down to two issues. One, humans are not rats,

0:01:00.876,0:01:04.964
and two, despite our incredible similarities to one another,

0:01:04.964,0:01:07.405
actually those tiny differences between you and I

0:01:07.405,0:01:09.914
have huge impacts with how we metabolize drugs

0:01:09.914,0:01:11.783
and how those drugs affect us.

0:01:11.783,0:01:14.615
So what if we had better models in the lab

0:01:14.615,0:01:17.885
that could not only mimic us better than rats

0:01:17.885,0:01:21.805
but also reflect our diversity?

0:01:21.805,0:01:25.732
Let's see how we can do it with tissue engineering.

0:01:25.732,0:01:28.261
One of the key technologies that's really important

0:01:28.261,0:01:31.453
is what's called induced pluripotent stem cells.

0:01:31.453,0:01:33.971
They were developed in Japan pretty recently.

0:01:33.971,0:01:36.418
Okay, induced pluripotent stem cells.

0:01:36.418,0:01:38.531
They're a lot like embryonic stem cells

0:01:38.531,0:01:40.748
except without the controversy.

0:01:40.748,0:01:43.647
We induce cells, okay, say, skin cells,

0:01:43.647,0:01:46.154
by adding a few genes to them, culturing them,

0:01:46.154,0:01:47.775
and then harvesting them.

0:01:47.775,0:01:50.482
So they're skin cells that can be tricked,

0:01:50.482,0:01:53.266
kind of like cellular amnesia, into an embryonic state.

0:01:53.266,0:01:55.978
So without the controversy, that's cool thing number one.

0:01:55.978,0:01:58.527
Cool thing number two, you can grow any type of tissue

0:01:58.527,0:02:01.082
out of them: brain, heart, liver, you get the picture,

0:02:01.082,0:02:03.605
but out of your cells.

0:02:03.605,0:02:07.170
So we can make a model of your heart, your brain

0:02:07.170,0:02:09.802
on a chip.

0:02:09.802,0:02:12.658
Generating tissues of predictable density and behavior

0:02:12.658,0:02:15.490
is the second piece, and will be really key towards

0:02:15.490,0:02:18.162
getting these models to be adopted for drug discovery.

0:02:18.162,0:02:21.274
And this is a schematic of a bioreactor we're developing in our lab

0:02:21.274,0:02:24.722
to help engineer tissues in a more modular, scalable way.

0:02:24.722,0:02:28.121
Going forward, imagine a massively parallel version of this

0:02:28.121,0:02:30.458
with thousands of pieces of human tissue.

0:02:30.458,0:02:34.506
It would be like having a clinical trial on a chip.

0:02:34.506,0:02:38.301
But another thing about these induced pluripotent stem cells

0:02:38.301,0:02:40.850
is that if we take some skin cells, let's say,

0:02:40.850,0:02:43.026
from people with a genetic disease

0:02:43.026,0:02:45.282
and we engineer tissues out of them,

0:02:45.282,0:02:47.250
we can actually use tissue-engineering techniques

0:02:47.250,0:02:50.651
to generate models of those diseases in the lab.

0:02:50.651,0:02:54.235
Here's an example from Kevin Eggan's lab at Harvard.

0:02:54.235,0:02:56.525
He generated neurons

0:02:56.525,0:02:59.240
from these induced pluripotent stem cells

0:02:59.240,0:03:01.869
from patients who have Lou Gehrig's Disease,

0:03:01.869,0:03:04.312
and he differentiated them into neurons, and what's amazing

0:03:04.312,0:03:07.464
is that these neurons also show symptoms of the disease.

0:03:07.464,0:03:09.563
So with disease models like these, we can fight back

0:03:09.563,0:03:12.145
faster than ever before and understand the disease better

0:03:12.145,0:03:16.108
than ever before, and maybe discover drugs even faster.

0:03:16.108,0:03:19.488
This is another example of patient-specific stem cells

0:03:19.488,0:03:23.497
that were engineered from someone with retinitis pigmentosa.

0:03:23.497,0:03:25.251
This is a degeneration of the retina.

0:03:25.251,0:03:28.008
It's a disease that runs in my family, and we really hope

0:03:28.008,0:03:30.232
that cells like these will help us find a cure.

0:03:30.232,0:03:33.040
So some people think that these models sound well and good,

0:03:33.040,0:03:36.481
but ask, "Well, are these really as good as the rat?"

0:03:36.481,0:03:39.469
The rat is an entire organism, after all,

0:03:39.469,0:03:41.175
with interacting networks of organs.

0:03:41.175,0:03:45.096
A drug for the heart can get metabolized in the liver,

0:03:45.096,0:03:47.936
and some of the byproducts may be stored in the fat.

0:03:47.936,0:03:52.463
Don't you miss all that with these tissue-engineered models?

0:03:52.463,0:03:54.577
Well, this is another trend in the field.

0:03:54.577,0:03:57.444
By combining tissue engineering techniques with microfluidics,

0:03:57.444,0:03:59.608
the field is actually evolving towards just that,

0:03:59.608,0:04:02.114
a model of the entire ecosystem of the body,

0:04:02.114,0:04:04.514
complete with multiple organ systems to be able to test

0:04:04.514,0:04:06.117
how a drug you might take for your blood pressure

0:04:06.117,0:04:09.384
might affect your liver or an antidepressant might affect your heart.

0:04:09.384,0:04:13.456
These systems are really hard to build, but we're just starting to be able to get there,

0:04:13.456,0:04:16.760
and so, watch out.

0:04:16.760,0:04:19.392
But that's not even all of it, because once a drug is approved,

0:04:19.392,0:04:23.074
tissue engineering techniques can actually help us develop more personalized treatments.

0:04:23.074,0:04:26.816
This is an example that you might care about someday,

0:04:26.816,0:04:28.936
and I hope you never do,

0:04:28.936,0:04:31.456
because imagine if you ever get that call

0:04:31.456,0:04:34.664
that gives you that bad news that you might have cancer.

0:04:34.664,0:04:37.200
Wouldn't you rather test to see if those cancer drugs

0:04:37.200,0:04:39.960
you're going to take are going to work on your cancer?

0:04:39.960,0:04:42.382
This is an example from Karen Burg's lab, where they're

0:04:42.382,0:04:45.288
using inkjet technologies to print breast cancer cells

0:04:45.288,0:04:47.759
and study its progressions and treatments.

0:04:47.759,0:04:50.312
And some of our colleagues at Tufts are mixing models

0:04:50.312,0:04:53.400
like these with tissue-engineered bone to see how cancer

0:04:53.400,0:04:56.120
might spread from one part of the body to the next,

0:04:56.120,0:04:58.504
and you can imagine those kinds of multi-tissue chips

0:04:58.504,0:05:01.489
to be the next generation of these kinds of studies.

0:05:01.489,0:05:03.911
And so thinking about the models that we've just discussed,

0:05:03.911,0:05:05.824
you can see, going forward, that tissue engineering

0:05:05.824,0:05:08.280
is actually poised to help revolutionize drug screening

0:05:08.280,0:05:11.058
at every single step of the path:

0:05:11.058,0:05:13.632
disease models making for better drug formulations,

0:05:13.632,0:05:17.503
massively parallel human tissue models helping to revolutionize lab testing,

0:05:17.503,0:05:21.728
reduce animal testing and human testing in clinical trials,

0:05:21.728,0:05:23.420
and individualized therapies that disrupt

0:05:23.420,0:05:27.008
what we even consider to be a market at all.

0:05:27.008,0:05:29.552
Essentially, we're dramatically speeding up that feedback

0:05:29.552,0:05:31.875
between developing a molecule and learning about

0:05:31.875,0:05:34.224
how it acts in the human body.

0:05:34.224,0:05:36.552
Our process for doing this is essentially transforming

0:05:36.552,0:05:41.413
biotechnology and pharmacology into an information technology,

0:05:41.413,0:05:44.392
helping us discover and evaluate drugs faster,

0:05:44.392,0:05:47.608
more cheaply and more effectively.

0:05:47.608,0:05:51.688
It gives new meaning to models against animal testing, doesn't it?

0:05:51.688,0:05:58.503
Thank you. (Applause)